Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$148.10
+2.02%
Mkt Cap $9.37B
Analyst Ratings
Buy
20
Hold
0
Sell
0
Price Target (18 analysts)
$123.25
Range $110.00 – $145.00
Implied Upside
-16.8%
Consensus $123.25 vs current $148.10